Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.029 AUD | -.--% | +7.41% | +31.82% |
May. 30 | Actinogen Medical Completes AU$3.9 Million Non-Renounceable Entitlement Offer | MT |
May. 15 | Actinogen Medical Opens AU$3.9 Million Entitlement Offer; Shares Down 7% | MT |
Sales 2024 * | 7.86M 5.23M | Sales 2025 * | 7.72M 5.13M | Capitalization | 73.28M 48.75M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 9.32 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 9.5 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.32% |
1 week | +7.41% | ||
1 month | -23.68% | ||
3 months | -12.12% | ||
6 months | +20.83% | ||
Current year | +31.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 21-03-14 | |
William Souter
DFI | Director of Finance/CFO | - | Feb. 04 |
Cheryl Townsend
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Morstyn
BRD | Director/Board Member | 73 | 17-11-30 |
Geoff Brooke
FOU | Founder | 68 | 99-03-22 |
Malcolm McComas
BRD | Director/Board Member | 68 | 19-04-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.029 | -.--% | 286,900 |
24-05-30 | 0.029 | +16.00% | 1,516,721 |
24-05-29 | 0.025 | -3.85% | 688,551 |
24-05-28 | 0.026 | +4.00% | 1,175,082 |
24-05-27 | 0.025 | -7.41% | 1,756,229 |
Delayed Quote Australian S.E., May 31, 2024 at 02:10 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+31.82% | 48.66M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- ACW Stock